Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

Share Price is delayed by 15 minutes
Get Live Data
4,554.00    14.00 (0.31%)
Bid:
4,562.00
Ask:
4,563.00
Spread: 1.00 (0.022%)
Market Cap: £28.96b
RKT Live PriceLast checked at - London Stock Exchange

Intraday Reckitt Share Chart

2024 SHARE BUYBACK PROGRAMME - SECOND TRANCHE

24 Sep 2024 08:00

RNS Number : 3966F
Reckitt Benckiser Group PLC
24 September 2024
Β 

RECKITT BENCKISER GROUP PLC

Β 

2024 SHARE BUYBACK PROGRAMME - SECOND TRANCHE

Β 

On 24 July 2024,Β Reckitt Benckiser Group plc ("Reckitt" or the "Company") announcedΒ its 2024Β Β£1 billionΒ share buyback programme (the "Programme"). On 26 July 2024, the Company announced commencement of the first tranche of this ProgrammeΒ to returnΒ up toΒ Β£250 millionΒ of capital to shareholdersΒ (the "First Tranche").

Reckitt today announces its intention to commence the second tranche of the Programme (the "Second Tranche")Β which will returnΒ a further up toΒ Β£250 millionΒ of capital to shareholders, and whichΒ will commence on the day following completion of the First Tranche (anticipated to be during September or October 2024).

ReckittΒ announces that, in connection with the Second Tranche, it has entered into an agreement with Numis Securities Limited ("DN") under which it has issued an instruction to DNΒ to manage the Second Tranche of the Programme. DN will, acting as riskless principal, purchase Ordinary Shares for an aggregate purchase price of no greater thanΒ Β£250 millionΒ and will simultaneously sell such Ordinary Shares on to the Company.

Any purchase of Ordinary Shares in relation to this announcement will be carried out on the London Stock Exchange and Multilateral Trading Facilities, as defined by the Directive 2014/65/EU on markets in financial instruments (including the delegated and implementing acts adopted under it) as implemented, retained, amended, extended, re-enacted or otherwise given effect in theΒ United KingdomΒ from 1 January 2021 and as amended or supplemented in theΒ United KingdomΒ thereafter, and executed in accordance with the Listing Rules andΒ Reckitt's generalΒ authority to make market purchases of Ordinary Shares.Β The shares will be purchased in accordance with the price and volume conditions set out in the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buyback programmes and stabilisation measures as implemented, retained, amended, extended, re-enacted or otherwise given effect in theΒ United KingdomΒ from 1 January 2021 and as amended or supplemented in theΒ United KingdomΒ thereafter.

Reckitt will issue a further announcement upon the commencement of the Second Tranche and will announce any market repurchase of Ordinary Shares no later than 7.30 a.m.Β on the business day following the calendar day on which the repurchase occurred.Β To the extent permitted by law, Ordinary Shares purchased under the Second Tranche of the Programme will be held in treasury. For the avoidance of doubt, no repurchases will be made in respect of the Company's American Depository Receipts.

Any further tranches of the Programme, which may be conducted after completion of the Second Tranche, will be announced in due course.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

CONTACT DETAILS:

Richard Joyce +44 (0)7807 418516

Investor Relations

Β 

Catheryn O'Rourke +44 (0) 1753 217 800

General Counsel & Company Secretary

Β 

Β About Reckitt:

Β 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us atΒ www.reckitt.com

* Reckitt is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSEZLBLZKLZBBF
Date   Source Headline
2nd Oct 20248:00 amRNSCOMPLETION OF FIRST TRANCHE
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 202412:20 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 20247:00 amRNSTransaction in Own Shares
27th Sep 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20248:00 amRNS2024 SHARE BUYBACK PROGRAMME - SECOND TRANCHE
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
16th Sep 20241:59 pmRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20242:04 pmRNSTotal Voting Rights
2nd Sep 20249:35 amRNSDirector/PDMR Shareholding
2nd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20244:08 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.